Table 2 Changes in clinical characteristics after 12 months of MHT.

From: Different effects of menopausal hormone therapy on non-alcoholic fatty liver disease based on the route of estrogen administration

 

Transdermal MHT (n = 75)

Oral MHT (n = 293)

Baseline

12 months

Baseline

12 months

Body mass index (kg/m2)

22.5 ± 3.0

22.5 ± 2.9

22.2 ± 2.8

22.1 ± 2.5

Waist circumference (cm)

74.2 ± 7.2

74.4 ± 7.1

74.5 ± 7.1

74.2 ± 7.2

Systolic blood pressure (mmHg)

114.8 ± 14.6

112.2 ± 13.8

112.6 ± 14.8

113.1 ± 15.3

Diastolic blood pressure (mmHg)

70.3 ± 10.0

67.6 ± 9.4*

68.9 ± 10.8

68.5 ± 11.4

  1. Data are presented as mean ± standard deviation.
  2. *P < 0.05 based on paired t test within each treatment.
  3. MHT menopausal hormone therapy.
Back to article page